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Abstract
Culture-negative endocarditis (CNE) is a challenging clinical entity, both diagnostically
and therapeutically. In this chapter, the changed epidemiology and microbiology of
CNE are reviewed with cases highlighting typical pathogens in patients pre-treated with
antibiotics, less common fastidious pathogens such as bacteria of the HACEK group,
nutritionally deficient bacteria, Legionella spp. and Mycobacteria, “quintessential” CNE
pathogens such as Bartonella spp., Coxiella burnetti and Tropheryma whipplei, as well as
fungal CNE. Contemporary diagnostic methods are reviewed including polymerase
chain  reaction-based  pathogen  16s  RNA  amplification  coupled  with  electrospray
ionization mass spectrometry (PCR/ESI-MS). Finally, treatment options per the recently
updated  2015  American  Heart  Association  and  European  Society  for  Cardiology
guideline are presented.
Keywords: culture-negative endocarditis, Bartonella spp., Coxiella burnetti and Tropher‐
yma whipplei, PCR/ESI-MS
1. Introduction
Culture-negative  endocarditis  (CNE)  is  one  of  the  most  challenging  infectious  diseases
clinical syndromes both diagnostically and therapeutically. The prevalence of CNE varies
widely in various modern series: it is estimated that on average, in 20% (range 5–71%) of
echocardiographically evident endocarditis, both native and prosthetic valve, blood cultures
do not yield a specific pathogen [1–7]. The morbidity but not necessarily mortality associated
with CNE is higher than in instances where a specific pathogen is found, primarily due to
the increased burden of diagnostic testing, delays in administration of antibiotics and the
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extended use  of  broad spectrum anti-microbial  agents  [8].  This  chapter  will  review the
epidemiology and likely microbiology of CNE, as well as enhanced diagnostic methods and
treatment recommendations.
A useful definition of CNE has been put forth by Tattevin et al. [9] wherein one can think of
this entity as (1) true bacterial endocarditis with blood cultures sterilized by previous receipt
of antimicrobials; (2) CNE caused by fastidious or unusual organisms such as the bacteria
known as the “HACEK” group, nutritionally deficient Streptococci, Pasturella spp., Helicobacter
spp., Mycobacteria and fungal organisms and (3) “true” CNE involving intracellular organ-
isms that are detectable via serology or polymerase chain reaction (PCR) of valvular tissue,
e.g. Bartonella quintana, Coxiella burnetti and Tropheryma whipplei. In addition, there are non-
infectious causes of endocarditis, e.g. murantic that will not be covered in this chapter.
2. Epidemiology of CNE
The epidemiology of infective endocarditis, and hence CNE, has changed over the last five
decades [5, 10]. Patients are generally older and male, with greater numbers of hospital
associated cases, and with indwelling devices such as catheters, pacemakers and prosthetic
valves. Accordingly the numbers of cases of infective endocarditis with Staphylococcus aureus,
coagulase-negative Staphylococci and Enterococci have increased. With the advent of novel
diagnostic methods (PCR-based testing), the prevalence of CNE may have decreased to 14.2%
[5] in the last decade, but other reviews indicate otherwise [10]. Specific aspects of the patient's
medical history may provide “epidemiological clues” (Table 6 in Ref. [1]) to the microbiological
cause. Military personnel have some higher risk of CNE due to C. burnetti for example [11].
3. Microbiology of CNE
The microbiology of CNE is varied and depends on host and environmental factors that
predispose to one type of pathogen versus another [1]. As per the classification of Tattevin et
al. [9], the microbiologic discussion will follow this paradigm.
3.1. CNE due to pre-treatment of typical bacterial endocarditis
According to one of the largest surveys of infective endocarditis recently performed, in the
last decade, 29.7% of IE were due to S. aureus, 17.6% were due to oral Streptococci, 10% were
due to coagulase-negative Staphylococci and 10% were due to Enterococci. Approximately,
16% of IE cases were thus due to Gram-negative bacteria, fungi and mycobacteria that could
be cultured from blood. Because the presentation of infective endocarditis can be non-specif-
ic and is often associated with clinical sepsis, patients receive empiric broad spectrum anti-
bacterials before sufficient numbers of blood cultures can be obtained. In one contemporary
survey, antibiotics were used before blood cultures 74% of the time, with many patients
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coming from outside hospitals before a diagnosis of endocarditis was established [4]. The
distribution of bacterial etiologies in these cases should represent what is seen generally
when blood cultures are obtained prior to initiation of antibiotics. PCR of valve tissue in the
cases where pretreatment occurred showed a predominance of Streptococcus oralis (54%),
Streptococcus aureus (7.7%) and Streptococcus gallolyticus (formerly known as Streptococcus bo‐
vis) 5.1%. This likely reflects the ability of these organisms to attach to endovascular epitheli-
um and be detectable by PCR methods.
3.2. CNE due to fastidious micro-organisms
3.2.1. HACEK group
Much of the early literature regarding CNE focused on infections with so-called “fastidious”
organisms that were traditionally difficult to grow in blood culture, due to specific nutritional
requirements of these organisms. These included a number of oral Gram-negative bacteria
(Haemophilus species, Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens and
Kingella species) that came to be known by the acronym “HACEK” (reviewed in [12]). Auto-
mated blood culture methodology involved the use of media that lacked particular nutrients
like hemin, and extended incubation of 3 weeks was recommended in order to isolate HACEK
group and other fastidious Gram negatives (ref). However, as early as 1993, it was evident that
extended incubation was no longer necessary in order to isolate these bacteria [13, 14]. Standard
5–7 day incubation was sufficient to recover an organism in most instances.
HACEK organisms are rarely the cause of infective endocarditis, and because of the improved
ability to isolate these organisms from standard blood culture specimens, even more rarely the
cause of CNE. In a recent series, four out of 77 patients with HACEK IE had negative blood
cultures [15]. Of these, three had previously received antibiotics. Diagnosis was made by
culture of devices, and in one patient, by PCR of valvular tissue. Cardiobacterium valvarum has
been described as an unusual Cardiobacterium spp. associated with endocarditis, in this case,
an infected aortic graft in a middle-aged man with gingivitis and a sub-acute bacterial
endocarditis presentation. In this case, the organism grew in blood culture but could not be
identified by routine microbiological examination. 16S rRNA analysis revealed the species.
Pediatric populations, especially young children between the ages of 6 months and four years,
appear to be particularly vulnerable to infections with Kingella kingae [16]. K. kingae is present
in the oropharynx and respiratory tract of young children and can be transmitted person-to-
person with resulting outbreaks of infection. K. kingae has a variety of colonization and
virulence factors such as pili that allows the organism to anchor itself to human mucosal
epithelium, polysaccharide capsule that decreases opsonization by complement, the ability to
produce exopolysaccharide and biofilm that is an important factor in the formation of
endovascular vegetations and RTX toxin, a potent cytotoxin that targets macrophages and
respiratory epithelium [17]. Fortunately, bacteremia and endocarditis are relatively rare
syndromes associated with this organism [16], causing 7.1–7.8% of pediatric endocarditis
cases [18, 19]. The presentation can be dramatic as illustrated in a child with mycotic aneurysm
of the aorta and cerebral infarcts [20].
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3.2.2. Non HACEK group organisms
Other fastidious bacteria causing CNE include Pasturella multocida and other Pasturella spp.
which constitute part of the normal oral flora of dogs and cats in particular [21]. While bite
wounds are obviously a portal of entry for Pasturella spp., in immunocompromised patients,
more superficial contact especially with cat fur, minor cat scratches and cat saliva can lead to
bacteremia and subsequent endocarditis [22]. Culture-negative endocarditis caused by
Abiotrophia defectiva and Granulicatella spp.—so-called nutritionally deficient Streptococci [23]
—can also be associated with infected intracranial aneurysms and may be difficult to isolate
in routine blood cultures [24]. Special consideration for length of therapy must be given and
is covered below. Clostridia and other anaerobic organisms [25] may be difficult to recover in
routine blood cultures if specimens are not handled appropriately. These organisms are likely
a rare cause of CNE, but true prevalence is unknown. Gemella spp. have been described rarely
as a cause of CNE [9, 21] including Gemella burgeri tricuspid valve endocarditis [26] and Gemella
hemolysans prosthetic valve endocarditits identified by PCR of prosthetic valve material and
requiring implantation of a total artificial heart as a bridge to transplantation [27]. Brucella
mellitensis is another unusual pathogen associated with culture-negative endocarditis [2],
especially in regions of the world where consumption of unpasteurized milk (cow, goat and
sheep) occurs. In one series of six patients subsequently found to have Brucella endocarditis,
only two patients had blood cultures that revealed the diagnosis [28]. Several different
Legionella spp. have been reported as causes of culture-negative endocarditis, both in native
valves and prosthetic valves. These include cases of Legionella pneumophila in an immunocom-
promised patient with pneumonitis, a positive BAL fluid Legionella antigen, and subsequent
BAL fluid and blood isolation of the organism when subcultured onto buffered charcoal yeast
extract agar (BCYE agar) [29]. Another CNE case with L. pneumophila was identified when the
patient presented with septic arthritis and the organism was identified from synovial fluid by
16s rDNA PCR and was subsequently found to have a new murmur and a mitral vegetation
[30]. Mycobacteria are another rare cause of CNE, especially in association with porcine
bioprosthetic valves [31]. This study from a reference laboratory conducted between 2010 and
2013 found PCR evidence of Mycobacterial infection in six out of 370 valve samples submitted
from patients with suspected CN [31] with five cases of Mycobacterium chelonae and one case
of M. lentiflavum***. While typically associated with immunodeficiency states, mycobacterial
infections have also been reported in immunocompetent hosts as in the case of a patient
with disseminated M. chelonae infection and resulting pacemaker CNE [32]. Special stains and
cultures for acid fast bacilli should be considered in patients with device-related CNE [33].
Finally there are also rare reports with unusual causes of endovascular infections such as CNE
in an immunocompromised patient on high dose corticosteroids [34] and infected aortic
aneurysm in an immunocompetent patient [35] with Helicobacter cinaedi.
3.3. CNE due to Bartonella spp., C. burnetti and T. whipplei
This section deals with CNE attributable to organisms that are not typically identified with
blood cultures but are responsible for a significant portion of cases of culture-negative infective
endocarditis [36].
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Bartonella endocarditis has been described as the “quintessential culture-negative endocardi-
tis” [37]. Bartonella species were first described as a cause of infectious endocarditis in 1993
(reviewed in [38]). A recent study in Brazil estimated that 19.6% of CNE cases were due to
Bartonella spp. [36]. There are currently 23 different species of Bartonella reported; the most
common etiology of CNE, however, is the result of louse transmitted B. quintana especially in
homeless persons, or infection with Bartonella henselae transmitted by contact with young cats.
B. henselae is more often associated with immunocompromised hosts and prosthetic valve
endocarditis [39–41]. Diagnosis of Bartonella CNE is typically made via serologies and/or PCR
of valvular material. Further modifications to the modified Duke diagnostic criteria for
endocarditis have been proposed to incorporate positive PCR, Western blot or serum IgG titer
≥800 as major criteria [38]. Unusual clinical presentations with severe renal impairment have
been described with Bartonella CNE where there is a delay in diagnosis including anti-
neutrophil cytoplasmic antibody (ANCA) positive necrotizing glomerulonephritis [42], C3
predominant glomerulonephritis [39] and proliferative glomerulonephritis (GN) with eryth-
roblastopenia [43]. One case of B. henselae tricuspid valve CNE was diagnosed after the patient
presented with chronic pulmonary emboli [44]. In this patient, the source was felt to be a tick
bite rather than exposure to cats.
C. burnetti is a rickettsial like organism associated with true CNE [9, 21]. In Brazil, it was
estimated that the prevalence of C. burnetti as a cause of CNE was 7.9% [36] by PCR and
serologic methods. In France, in the 1990s, annual incidence was estimated at 1 per million or
<5% of all cases of endocarditis [45]. Acquisition in humans is usually through exposure to
parturient animals such as sheep [21]. Presentation can be quite severe especially in immuno-
compromised persons, pregnant women and in persons with prosthetic valves or native
valvular heart disease [46]. A new genotype, MST 54 [47] was recently described in a child with
CNE secondary to congenital heart disease from an area endemic for C. burnetti.
T. whipplei is an Actinomycete bacterium found in the stool and environment [48]. Stool carriage
in uninfected humans can be detected in the range of wards of 4–31%. An infectious cause of
lipodystrophia intestinalis, later known as Whipple's disease, was first proposed by George
Whipple in 1907 based on the presence of lipid laden foamy macrophages in the lamina propria
of the small intestine. Clinical manifestations are protean, but generally patients present with
diarrhea, weight loss, fever and malabsorption. T. whipplei is a known cause of CNE, and its
true prevalence may be underestimated. When associated with arthralgia in middle-age men,
it is almost pathognomonic for T. whipplei as the etiologic agent [49, 50]. While the organism
can be cultured in fibroblasts [48], diagnosis of CNE typically requires PCR analysis of valvular
tissue [51].
3.4. CNE due to fungal pathogens
Invasive mold infections are another cause of CNE, due to the difficulty in isolating these
organisms from routine blood cultures. They are an important cause especially of early culture-
negative prosthetic valve endocarditis [52] but can cause late prosethetic valve, pacemaker
associated as well as native valve endocarditis. Among cases in the recent literature, infec-
tions with Aspergillus spp. [53–55], Histoplasma capsulatum [56–58] and Trichosporin spp. [59,
Culture Negative Endocarditis: Advances in Diagnosis and Treatment
http://dx.doi.org/10.5772/64920
107
60] are the most widely reported. Commercial tests that detect fungal wall antigens such as
galactomannan [2, 61, 62] and β-1,3-D-glucan [62] can show good sensitivity and specificity in
diagnosis of fungal CNE. Jinno et al. [56] reported negative urine Histoplasma antigen results
in their patient with H. capsulatum CNE, with diagnosis based on valvular pathology and tissue
culture.
4. Diagnostic methods
Our understanding of the etiology of CNE and our ability to offer more targeted treatment to
patients with CNE have been dramatically affected by the large number of novel diagnostic
tests now available to add to our investigative armamentarium. The following discussion will
focus on methods that allow diagnosis without removal of infected valves or cardiac devices
(prosthetic valves, endovascular grafts, pacemaker and defibrillator leads, ventricular assist
devices, etc.) versus methods that require removal of tissue or a device for diagnostic and
therapeutic reasons.
4.1. Non-invasive methods
Imaging using positron emission tomography (PET) scanning has been utilized to diagnose
a case of T. whipplei endocarditis [63]. The infected prosthetic valve was subsequently re-
moved providing material for PCR-based methods to confirm the diagnosis, but the impe-
tus to remove the valve came from the PET scan. Four-dimensional cardiac MRI was used
to better define valvular damage and diagnose aortic valve endocarditis in a case of C. bur‐
netti CNE in a patient with exposure to domesticated buffalos and positive serologies [64].
PCR combined with electrospray ionization mass spectrometry (PCR/ESI-MS) methods
have been applied to detect pathogens in blood cultures in patients already receiving anti-
biotics and made a diagnosis in 41 out of 410 cases, although not specifically in persons
with CNE [65]. Broad range PCR on blood culture specimens has also been utilized [2].
Serum galactomannan and β-1,3-D-glucan have already been mentioned as serum diagnos-
tic tests for fungal CNE [2, 61, 62].
4.2. Invasive methods
Methodologies to increase numbers of planktonic organisms that can be cultured from devi-
ces have been devised, using sonication of the devices [66, 67]. Metagenomic analysis of the
results of next generation sequencing has been used to diagnose A. defectiva CNE [68]. A uni-
versal PCR/sequencing test has been applied to diagnose CNE on blood and valvular tissue
[69]. Immunofluorescent antibody detection, Western blot analysis and real time-PCR of 16s
RNA have been used to diagnose CNE due to Bartonella spp. [38]. PCR/ESI-MS has been uti-
lized on valve tissue to diagnose CNE [70, 71].
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5. Treatment of CNE
There are some distinct differences in the management of infective endocarditis according to
the United States [1] versus European guidelines [72] updated in 2015. These are reviewed in
Tattevin et al. [73]. However, in regard to treatment of the following etiologic agents of CNE,
there is good agreement in general.
5.1. Empiric therapy for CNE
For patients with acute clinical presentations of native valve endocarditis, according to the US
guidelines, empiric coverage for S. aureus, β-hemolytic Streptococci and aerobic Gram-negative
bacilli is provided. Such regimens should include vancomycin and cefepime at the beginning.
For patients with a subacute presentation of native valve endocarditis, additional empirical
coverage of viridans Streptococci, HACEK and Enterococci is added. Vancomycin and ampicil-
lin-sulbactam is a suggested regimen. If blood cultures eventually become positive for a typical
pathogen, empiric treatment can be tailored accordingly. For patients with early (<1 year)
culture-negative prosthetic valve endocarditis, empiric coverage for Staphylococci, Streptococci,
Enterococci and Gram-negative bacilli is appropriate. Vancomycin, rifampin, gentamicin and
cefepime are offered as options. For late prosthetic valve endocarditis, antibiotic therapy to
cover viridans Streptococci, Staphylococci and Enterococci such as vancomycin and ceftriaxone is
suggested. Empiric antibiotics can be narrowed based on specific pathogens that are subse-
quently identified. Surgical source control and removal of infected devices are required more
often with the pathogens associated with CNE.
5.2. A. defectiva, Granulicatella spp.
As summarized in the European guidelines, these nutritionally deficient bacteria produce
endocarditis with a protracted course which is associated with large vegetations (≥10 mm),
higher rates of complications and valve replacement (around 50%), possibly due to delayed
diagnosis and treatment. Antibiotic recommendations include penicillin G, ceftriaxone or
vancomycin for 6 weeks, combined with an aminoglycoside for at least the first 2 weeks.
6. HACEK
Per the US and European guidelines, microbiologic susceptibility testing might be difficult to
perform on HACEK microorganisms, and they should be considered ampicillin resistant
secondary to β-lactamase production. Penicillin and ampicillin should not be used for the
treatment of patients with endocarditis. Ceftriaxone should be used unless the patient has a
severe β-lactam allergy. The duration of therapy for HACEK native valve endocarditis is 4
weeks; for prosthetic valve infections, duration of therapy is 6 weeks or longer. Gentamicin is
not recommended in the US guidelines because of its nephrotoxicity risks but is an option in
the European guidelines. A fluoroquinolone (ciprofloxacin, levofloxacin, ormoxifloxacin) can
be used in patients with a β-lactam allergy. Ampicillin-sulbactam is also a treatment option.
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Bartonella spp. Doxycycline 100 mg/12 h orally for 4 weeks
plus gentamicin (3 mg/24 h) i.v. for 2 weeks
Brucella spp. Doxycycline (200 mg/24 h)
plus cotrimoxazole (960 mg/12 h)
plus rifampin (300–600/24 h)
for ≥3–6 months orally
Coxiella burnetti Doxycycline (200 mg/24 h)
plus hydroxychloroquine (200–600 mg/24 h) orally
(>18 months of treatment)
Legionella spp. Levofloxacin (500 mg/12 h) i.v. or orally for ≥6 weeks
or clarithromycin (500 mg/12 h) i.v. for 2 weeks, then
orally for 4 weeks
plus rifampin (300–1200 mg/24 h)
T. whipplei Doxycycline (200 mg/24 h)
plus hydroxychloroquine (200–600 mg/24 h)c orally for
≥18 months
Treatment of the following unusual pathogens in CNE is best summarized in the European
guidelines and in Broqui et al. [21].
7. Fungal CNE
Per the European guidelines, for Aspergillus infections, voriconazole is the drug of choice, and
some experts recommend the addition of an echinocandin or amphotericin B. Surgery is
generally required, and prolonged suppressive therapy is recommended. For H. capsulatum,
surgical management followed by 6 weeks of amphotericin B and additional suppressive oral
itraconazole is recommended. Most agents have poor activity against other mold species like
Trichosporon spp. The mainstay of therapy is surgical.
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